Studies have shown, that HPV-based screening is more sensitive than cytology-based screening, but local factors will influence the performance. From January 2021 phased implementation of HPV-based screening was introduced in the Danish cervical cancer screening programme to women between 30 and 59 years. Women with even birth dates will remain on the current cytology-based screening, whereas women with odd birth dates will receive HPV-based screening. The aim of the implementation is to provide guidance to the National Health Authority on the future Danish cervical screening, as argued in this review.
|Bidragets oversatte titel||Phased implementation of HPV-based cervical cancer screening in Denmark|
|Tidsskrift||Ugeskrift for laeger|
|Status||Udgivet - 28 feb. 2022|